Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Stephen Wanaski"'
Autor:
Timothy Cunniff, Donald Gilbert, Stephen Wanaski, Richard Bittman, Jordan Dubow, Atul Mahableshwarkar
Publikováno v:
Wednesday, April 26.
Autor:
Soha Freidy, Teodora Dumitrescu, Virginia Schmith, Donald Gilbert, Atul Mahableshwarkar, Jordan Dubow, Timothy Cunniff, David Kim, Meredith Miller, Stephen Wanaski
Publikováno v:
Monday, April 24.
Autor:
Ihor Bekersky, Stephen D. Collins, Dwain Tolbert, Reid Patterson, Bernard S Jortner, Stephen Wanaski, Stephen M. Sagar, Mark Walzer, Robert H. Garman
Publikováno v:
NeuroToxicology. 32:963-974
Two toxicologic studies of vigabatrin were conducted with immature Sprague Dawley rats to characterize intramyelinic edema (IME) formation and assess potential impact on behavioral measures. Study 1 was a dosage-ranging characterization of overall to
Autor:
Aida Habtezion, Stephen D. Collins, Raymond Kwan, Alice L. Yang, Eugene C. Butcher, Maureen Morgan, M. Bishr Omary, Ehsaan Akhtar, Ahmad Kamal, Stephen Wanaski
Publikováno v:
American Journal of Physiology-Gastrointestinal and Liver Physiology. 300:G12-G20
Heme oxygenase-1 (HO-1) induction by hemin or Panhematin protects against experimental pancreatitis. As a preclinical first step toward determining whether HO-1 upregulation is a viable target in acute pancreatitis (AP) patients, we tested the hypoth
Autor:
Stephen D. Collins, Raymond Kwan, M. Bishr Omary, Eugene C. Butcher, Stephen Wanaski, David K. Stevenson, Ehsaan Akhtar, Aida Habtezion, Ronald J. Wong
Publikováno v:
Gut. 60:671-679
Background and aim Acute pancreatitis (AP) can result in pancreatic necrosis and inflammation, with subsequent multi-organ failure. AP is associated with increased neutrophil recruitment and a rise in pro-inflammatory cytokines such as TNFα. Pretrea
Autor:
Stephen Wanaski, Stephen M. Collins, Edward L. LeCluyse, Alison H. Harrill, Paul B. Watkins, John M. Cullen, Lakshmi Ramanathan, Yu Ho, Kelly Rose, John S. Eaddy
Publikováno v:
Toxicology and applied pharmacology. 277(2)
NP260 was designed as a first-in-class selective antagonist of α4-subtype GABAA receptors that had promising efficacy in animal models of pain, epilepsy, psychosis, and anxiety. However, development of NP260 was complicated following a 28-day safety
Autor:
Ahmad Kamal, Aida Habtezion, Alice L. Yang, Ehsaan Akhtar, Raymond Kwan, Bishr Omary, Stephen M. Collins, Eugene C. Butcher, Maureen Morgan, Stephen Wanaski
Publikováno v:
Gastroenterology. 134:A-372
Autor:
Bishr Omary, Stephen M. Collins, Hui Ye Zheng, Raymond Kwan, Aida Habtezion, Eugene C. Butcher, Stephen Wanaski, Ehsaan Akhtar
Publikováno v:
Gastroenterology. 134:A-430